Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 221460 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-03-01 |
| Estimated end date | 2024-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-06 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we have encountered a supply interruption on our Sodium Chloride Injection, USP 4 mmol/ml PBV 100 mL effective March 1, 2024, until April 30,2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-03-06 | French | Compare |
| v1 | 2024-03-06 | English | Compare |
Showing 1 to 2 of 2